Neuromolecular medicine, 2024-01, Vol.26 (1), p.1-1, Article 1
2024
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Amelioration of Astrocyte-Mediated Neuroinflammation by EI-16004 Confers Neuroprotection in an MPTP-induced Parkinson’s Disease Model
- Ist Teil von
- Neuromolecular medicine, 2024-01, Vol.26 (1), p.1-1, Article 1
- Ort / Verlag
- New York: Springer US
- Erscheinungsjahr
- 2024
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Parkinson’s disease (PD) is a neurodegenerative disorder that results in motor impairment due to dopaminergic neuronal loss. The pathology of PD is closely associated with neuroinflammation, which can be characterized by astrocyte activation. Thus, targeting the inflammatory response in astrocytes might provide a novel therapeutic approach. We conducted a luciferase assay on an in-house chemical library to identify compounds with anti-inflammatory effects capable of reducing MPP + -induced NF-κB activity in astrocytes. Among the compounds identified, EI-16004, a novel 3-benzyl- N -phenyl-1 H -pyrazole-5-carboxamides, exhibited a significant anti-inflammatory effect by significantly reducing MPP + -induced astrocyte activation. Biochemical analysis and docking simulation indicated that EI-16004 inhibited the MPP + -induced phosphorylation of p65 by attenuating ERK phosphorylation, and EI-16004 reduced pro-inflammatory cytokine and chemokine levels in astrocytes. In vivo studies on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model in male C57BL/6 mice showed that EI-16004 ameliorated motor impairment and protected against dopaminergic neuronal loss, and EI-16004 effectively mitigated the MPTP-induced astrocyte activation in striatum (STR) and substantia nigra (SN). These results indicate EI-16004 is a potential neuroprotective agent for the prevention and treatment of astrocyte-mediated neuroinflammatory conditions in PD.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1559-1174, 1535-1084eISSN: 1559-1174DOI: 10.1007/s12017-023-08769-8Titel-ID: cdi_proquest_miscellaneous_2920571685
- Format
- –
- Schlagworte
- Animals, Anti-Inflammatory Agents, Astrocytes, Biochemical analysis, Biomedical and Life Sciences, Biomedicine, Chemokines, Dopamine, Dopamine receptors, Inflammation, Internal Medicine, Male, Mice, Mice, Inbred C57BL, Movement disorders, MPP, MPTP, Neostriatum, Neurodegenerative diseases, Neuroinflammatory Diseases, Neurology, Neuroprotection, Neurosciences, NF-κB protein, Parkinson Disease - drug therapy, Parkinson Disease - etiology, Parkinson's disease, Phosphorylation, Pyrazoles, Substantia nigra